Polanco-Flores NA, Rodríguez-Castellanos F

Language: Spanish
References: 18
Page: 198-207
PDF size: 213.90 Kb.

ABSTRACT

Background: Diabetic nephropathy is the first cause of chronic kidney disease and renal function replacement worldwide.
Objective: To evaluate the risk factors of initiation-progression of diabetic nephropathy.
Material and Method: A cross-sectional, retrospective, descriptive study, through analysis of renal function tests, such as the creatinine and albuminuria clearance of 24 hours, an intentional search of abnormal findings was carried out from January to December 2018 in the external consultation of a second level general hospital. The data was analyzed using the statistical package SPSS version 15 for Windows.
Results: There were included 56 patients. It was possible to detect diabetic nephropathy in 61% of the population against 30% by means of techniques traditionally used in the general consultation of diabetic patients. Active smoking [OR 3.500 (95%CI, 1188-22211)] and persistent hyperglycemia were found as the main factors associated with the development of nephropathy [OR 2.143 (95%CI, 1.145-4.009)], constituting the level of prolonged suboptimal control the common denominator that differentiates them from the population without diabetic nephropathy (p = 0.002).
Conclusions: Active smoking and persistent hyperglycemia were found as the main factors associated with the development of nephropathy.

REFERENCES

1. Eckardt K, Coresh J, Devuyst O, Johnson R, Köttgen A, Levey A, et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet 2013;382(9887):158-169.

2. Annual Data Report 2012 de Unites States Renal Data System. Disponible en: www.usrds.org/adr.htm. [Consultado el 22 agosto de 2017]

3. Registro de la Sociedad Española de Nefrología. Disponible en: www.senefro.org/ [Informe anual del registro SEN-ONT de enfermos renales (GRER). XLVI Congreso Anual SEN, Octubre 2016, Oviedo. [Consultado el 22 de agosto de 2017]

4. Méndez-Durán A, Méndez-Bueno J, Tapia-Yáñez T, Muñoz-Montes A, Aguilar-Sánchez L. Epidemiología de la insuficiencia renal crónica en México. Dial Traspl 2010;31(1):7-11.

5. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27(5):1047-53.

6. Ruospo M, Saglimbene VM, Palmer SC, De Cosmo S, Pacilli A, Lamacchia O, et al. Glucose targets for preventing diabetic kidney disease and its progression. Cochrane Database Syst Rev 2017;8(6).

7. MacIsaac RJ, Jerums G, Ekinci EI. Effects of glycaemic management on diabetic kidney disease. World J Diabetes 2017;8(5):172-186.

8. Yokoyama H, Okudaira M, Otani T, Sato A, Miura J, Takaike H, et al. Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan. Kidney Int 2000;58:302-11.

9. Hasslacher CH, Ritz E, Wahl P, Michael C. Similar risks of nephropathy in patients with type I or type II diabetes mellitus. Nephrol Dial Transplant 1989;4:859-63.

10. Tan J, Zwi LJ, Collins JF, Marshall MR, Cundy T. Presentation, pathology and prognosis of renal disease in type 2 diabetes. BMJ Open Diabetes Res Care 2017;11:5(1).

11. Tziomalos K, Athyros VG. Diabetic nephropathy: new risk factors and improvement in diagnosis. Rev Diabet Stud 2015;12(1-2):110-8.

12. Parving HH, Mauer M, Fioretto P, Rossing P, Ritz E. Diabetic Nephropathy. In: Taal MW, Chertow GM, Marsden PA, Skorecki K, Yu ASL, Brenner BM. Brenner & Rector’s The Kidney. Philadelphia, Elsevier Saunders, 9th ed., 2012;35(1411-1437).

13. Fioretto P, Mauer SM, Bilous RW, Goetz FC, Sutherland DE, Steffes MW. Effects of pancreas transplantation of glomerular structure in insulin-dependent diabetic patients with their own kidneys. Lancet 1993;342:1193-1196.

14. Fioretto P, Mauer M. Reversal of diabetic nephropathy: lessons from pancreas transplantation. J Nephrol 2012;25(1):13.8.

15. Fioretto P, Barzon I, Mauer M. Is diabetic nephropathy reversible? Diabetes Res Clin Pract 2014;104(3):323-8.

16. American Diabetes Association. Standards of medical care in diabetes 2015. Diabetes Care 2015;38(Suppl 1):S1-S94.

17. Asociación Latinoamericana de Diabetes. Prevención, diagnóstico y tratamiento temprano de la nefropatía diabética. Recomendaciones de la Asociación Latinoamericana de Diabetes (ALAD) avalado por la Sociedad Latinoamericana de Nefrología e Hipertensión (SLANH). Consensos ALAD, 2016. Descargado y consultado de http:// alad-americalatina.org/wp-content/uploads/2016/10/ PREVENCION-DE-NEFROPATIA en fecha 10 diciembre 2017.

18. Guía de práctica clínica prevención, diagnóstico y tratamiento de la enfermedad renal crónica temprana, México; Secretaría de Salud, 2009.